2008
DOI: 10.1016/j.vaccine.2008.03.070
|View full text |Cite
|
Sign up to set email alerts
|

HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
30
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(30 citation statements)
references
References 32 publications
0
30
0
Order By: Relevance
“…Potent immunogenic performance of all three HIV enzymes is a prerequisite of the efficacy of such immunotherapy. We and others performed series of studies aimed to improve the immunogenicity of RT, a key enzyme determining HIV-1 resistance to antiretroviral therapy, but with a limited success [12, 13, 1618]. Lately, we found that cells expressing HIV-1 RT produce reactive oxygen species (ROS) and express high levels of phase II detoxifying enzymes that interfere with the immune response against this enzyme [19, 20].…”
Section: Introductionmentioning
confidence: 99%
“…Potent immunogenic performance of all three HIV enzymes is a prerequisite of the efficacy of such immunotherapy. We and others performed series of studies aimed to improve the immunogenicity of RT, a key enzyme determining HIV-1 resistance to antiretroviral therapy, but with a limited success [12, 13, 1618]. Lately, we found that cells expressing HIV-1 RT produce reactive oxygen species (ROS) and express high levels of phase II detoxifying enzymes that interfere with the immune response against this enzyme [19, 20].…”
Section: Introductionmentioning
confidence: 99%
“…The use of protein degradation signals, which direct proteins to the proteasome via an ubiquitin–independent mechanism, circumvents the effects of a multitude of factors and thus provides a more straight–forward way of proteasome targeting. Fusion of HIV–1 reverse transcriptase with the minimal proteasome–targeting signals of ODC represented by two short amino acid sequences at the ODC C–terminus led to an accelerated degradation and an increased immunogenicity of the chimeric gene in mice as compared to the original gene [40]. This modification was also successful when applied to the weakly immunogenic reverse transcriptase of drug–resistant HIV–1 [41] helping to enhance both cellular and antibody immune responses against the mutant enzyme form [42].…”
Section: Ubiquitin-independent Mechanismmentioning
confidence: 99%
“…Chimeric fusion proteins fused to the N terminus of ODC promote the proteasome-dependent degradation of ODC and their interacting cellular target proteins (Matsuzawa et al, 2005). Moreover, it was reported that mice immunized with DNA encoding HIV-1 reverse transcriptase (RT) fused to ODC or the ODC signal domain showed marked enhancement of RT degradation and the immune response (Starodubova et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, mouse ODC fusion proteins were tested by transfection of human embryonic kidney cells (HEK293), and the effect of ODC activity on proteasomal degradation was confirmed by Western blot and cycloheximide chase experiments ( Johnson et al, 1992). There is also a report that antigen fusion with the signal domain of ODC induces a stronger immune response than fusion with full-length ODC (Starodubova et al, 2008). The C-terminal region of ODC (amino acids 423-461), which contains PEST domains, is essential for its degradation (Murakami et al, 2000).…”
mentioning
confidence: 99%